Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (vol 165, pg 329, 2017)

被引:0
|
作者
Cortes, Javier [1 ,2 ]
Rugo, Hope S. [3 ]
Awada, Ahmad [4 ]
Twelves, Chris [5 ,6 ]
Perez, Edith A. [7 ]
Im, Seock-Ah [8 ]
Gomez-Pardo, Patricia [9 ]
Schwartzberg, Lee S. [10 ]
Dieras, Veronique [11 ]
Yardley, Denise A. [12 ]
Potter, David A. [13 ]
Mailliez, Audrey [14 ]
Moreno-Aspitia, Alvaro [1 ,2 ]
Ahn, Jin-Seok [15 ]
Zhao, Carol [16 ]
Hoch, Ute [16 ]
Tagliaferri, Mary [16 ]
Hannah, Alison L.
O'Shaughnessy, Joyce [17 ]
机构
[1] Ramon y Cajal Univ Hosp, Madrid, Spain
[2] Vall dHebron Inst Oncol, Barcelona, Spain
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Jules Bordet Inst, Med Oncol Clin, Brussels, Belgium
[5] Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England
[6] St James Univ Hosp, Leeds, W Yorkshire, England
[7] Mayo Clin, Jacksonville, FL 32224 USA
[8] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul Natl Univ Hosp, Seoul, South Korea
[9] Vall dHebron Inst Oncol, Barcelona, Spain
[10] West Clin, Memphis, TN USA
[11] Inst Curie, Paris, France
[12] Sarah Cannon Res Inst, Nashville, TN USA
[13] Univ Minnesota, Dept Med, Masonic Canc Ctr, Box 736 UMHC, Minneapolis, MN 55455 USA
[14] Ctr Oscar Lambret, Lille, France
[15] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea
[16] Nektar Therapeut, San Francisco, CA USA
[17] US Oncol, Texas Oncol Baylor Charles A Sammons Canc Ctr, 3410 Worth St,Suite 400, Dallas, TX 75246 USA
关键词
D O I
10.1007/s10549-017-4482-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:327 / 328
页数:2
相关论文
共 50 条
  • [1] Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
    Cortes, Javier
    Rugo, Hope S.
    Awada, Ahmad
    Twelves, Chris
    Perez, Edith A.
    Im, Seock-Ah
    Gomez-Pardo, Patricia
    Schwartzberg, Lee S.
    Dieras, Veronique
    Yardley, Denise A.
    Potter, David A.
    Mailliez, Audrey
    Moreno-Aspitia, Alvaro
    Ahn, Jin-Seok
    Zhao, Carol
    Hoch, Ute
    Tagliaferri, Mary
    Hannah, Alison L.
    O'Shaughnessy, Joyce
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (02) : 329 - 341
  • [2] Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
    Javier Cortés
    Hope S. Rugo
    Ahmad Awada
    Chris Twelves
    Edith A. Perez
    Seock–Ah Im
    Patricia Gómez-Pardo
    Lee S. Schwartzberg
    Veronique Diéras
    Denise A. Yardley
    David A. Potter
    Audrey Mailliez
    Alvaro Moreno-Aspitia
    Jin-Seok Ahn
    Carol Zhao
    Ute Hoch
    Mary Tagliaferri
    Alison L. Hannah
    Joyce O’Shaughnessy
    Breast Cancer Research and Treatment, 2017, 165 : 329 - 341
  • [3] Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial
    Javier Cortés
    Hope S. Rugo
    Ahmad Awada
    Chris Twelves
    Edith A. Perez
    Seock–Ah Im
    Patricia Gómez-Pardo
    Lee S. Schwartzberg
    Veronique Diéras
    Denise A. Yardley
    David A. Potter
    Audrey Mailliez
    Alvaro Moreno-Aspitia
    Jin-Seok Ahn
    Carol Zhao
    Ute Hoch
    Mary Tagliaferri
    Alison L. Hannah
    Joyce O’Shaughnessy
    Breast Cancer Research and Treatment, 2017, 166 : 327 - 328
  • [4] Renal safety of ibandronate in patients with bone metastases from breast cancer:: phase III trial results
    Bell, R.
    Diel, I. J.
    Body, J.
    Bergstroem, B.
    EJC SUPPLEMENTS, 2004, 2 (03): : 132 - 132
  • [5] Ibandronate is effective in preventing skeletal events in patients with bone metastases secondary to breast and colorectal cancer - Results from a randomized phase III trial
    Heras, P
    Karagiannis, S
    Kritikos, K
    Hatzopoulos, A
    Georgopoulou, P
    Mitsibounas, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P66 - P67
  • [6] Ibandronate is effective in preventing skeletal events in patients with bone metastases secondary to breast and colorectal cancer - Results from a randomized phase III trial
    Heras, P
    Karagiannis, S
    Kritikos, K
    Hatzopoulos, A
    Georgopoulou, PA
    CANCER TREATMENT REVIEWS, 2005, 31 : S51 - S51
  • [7] Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases Final Results From the Phase 3 ATTAIN Randomized Clinical Trial
    Tripathy, Debu
    Tolaney, Sara M.
    Seidman, Andrew D.
    Anders, Carey K.
    Ibrahim, Nuhad
    Rugo, Hope S.
    Twelves, Chris
    Dieras, Veronique
    Mueller, Volkmar
    Du, Yining
    Currie, Sue L.
    Hoch, Ute
    Tagliaferri, Mary
    Hannah, Alison L.
    Cortes, Javier
    JAMA ONCOLOGY, 2022, 8 (07) : 1047 - 1052
  • [8] Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine (vol 35, pg 3433, 2017)
    Demetri, G. D.
    Schofski, P.
    Grignani, G.
    Blay, J. Y.
    Maki, R. G.
    Van, Tine B. A.
    Alcindor, T.
    Jones, R. L.
    D'Adamo, D. R.
    Guo, M.
    Chawla, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04) : 432 - 432
  • [9] Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer (vol 22, pg 494, 2017)
    Suto, Takeshi
    Ishiguro, Megumi
    Hamada, Chikuma
    Kunieda, Katsuyuki
    Masuko, Hiroyuki
    Kondo, Ken
    Ishida, Hideyuki
    Nishimura, Genichi
    Sasaki, Kazuaki
    Morita, Takayuki
    Hazama, Shoichi
    Maeda, Koutarou
    Mishima, Hideyuki
    Ike, Hideyuki
    Sadahiro, Sotaro
    Sugihara, Kenichi
    Okajima, Masazumi
    Saji, Shigetoyo
    Sakamoto, Junichi
    Tomita, Naohiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (04) : 805 - 806
  • [10] First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial
    Masuda, Norikazu
    Takahashi, Masato
    Nakagami, Kazuhiko
    Okumura, Yasuhiro
    Nakayama, Takahiro
    Sato, Nobuaki
    Kanatani, Kazumitsu
    Tajima, Kosei
    Kashiwaba, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (05) : 385 - 392